FDA Clears Evolva's IND For EV-077 In Influenza
Evolva Holding SA (SIX: EVE) today announced that the US Food and Drug Administration (FDA) has cleared Evolva's request to test EV-077 in man, under an Investigational New Drug (IND) application for influenza. Neil Goldsmith, CEO and Managing Director of Evolva commented: "This regulatory clearance by the FDA is an important milestone in the development of EV-077. In preclinical testing, EV-077 ...

FDA Warns Consumers To Stop Using Soladek Vitamin Solution
The U.S. Food and Drug Administration is warning consumers to stop using Soladek, a vitamin-solution product marketed by Indo Pharma, S.A., of the Dominican Republic, because the product may contain dangerously high levels of vitamins A and D. Soladek is marketed with claims that the product treats "hypo and avitaminosis, rickets, growth, dentition, lactation, fractures, infection, convalescence ...